SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Chelsea Therapeutics International, Ltd.

  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Chelsea
  Therapeutics International, Ltd.

Business Wire

BALA CYNWYD, Pa. -- May 9, 2014

Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Chelsea Therapeutics
International, Ltd. (“Chelsea” or the “Company”) (Nasdaq: CHTP) relating to
the proposed acquisition by H. Lundbeck A/S (“Lundbeck”).

Click here to learn more about the investigation
http://brodsky-smith.com/756-chtp-chelsea-therapeutics-international-ltd.html,
or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Chelsea shareholders will receive only
$6.44 in cash and up to an additional $1.50 in a Contingent Value Right for
each share of Chelsea stock they own. The investigation concerns possible
breaches of fiduciary duty and other violations of state law by the Board of
Directors of Chelsea for not acting in the Company’s shareholders' best
interests in connection with the sale process. The transaction may undervalue
the Company given the strong demand for Chelsea’s recently FDA-approved
Parkinson’s disease treatment Northera, which treats low blood pressure. In
addition, an analyst has set a $12.00 per share price target on Chelsea stock.

If you own shares of Chelsea common stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions, you may
e-mail or call the law office of Brodsky & Smith, LLC who will, without
obligation or cost to you, attempt to answer your questions. You may contact
Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC,
Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, by visiting
http://brodsky-smith.com/756-chtp-chelsea-therapeutics-international-ltd.html,
or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise
representing shareholders throughout the nation in securities and case action
lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous
courts throughout the country to serve as lead counsel in class actions and
successfully recovered millions of dollars for our clients and shareholders.
Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:

Brodsky & Smith, LLC
Jason L. Brodsky, Esquire
Evan J. Smith, Esquire
877-LEGAL-90
investorrelations@brodsky-smith.com
http://brodsky-smith.com/756-chtp-chelsea-therapeutics-international-ltd.html
 
Press spacebar to pause and continue. Press esc to stop.